Log in to save to my catalogue

Adherence to treatment guidelines in clinical practice: study of antipsychotic treatment prior to cl...

Adherence to treatment guidelines in clinical practice: study of antipsychotic treatment prior to cl...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1323338191

Adherence to treatment guidelines in clinical practice: study of antipsychotic treatment prior to clozapine initiation

About this item

Full title

Adherence to treatment guidelines in clinical practice: study of antipsychotic treatment prior to clozapine initiation

Publisher

Cambridge, UK: Cambridge University Press

Journal title

British journal of psychiatry, 2012-12, Vol.201 (6), p.481-485

Language

English

Formats

Publication information

Publisher

Cambridge, UK: Cambridge University Press

More information

Scope and Contents

Contents

Clozapine is the only antipsychotic drug licensed for treatment-resistant schizophrenia but its use is often delayed. Since previous studies, national guidelines on the use of clozapine and other antipsychotics have been disseminated to clinicians.
To determine the theoretical delay to clozapine initiation and to quantify the prior use of antips...

Alternative Titles

Full title

Adherence to treatment guidelines in clinical practice: study of antipsychotic treatment prior to clozapine initiation

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1323338191

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1323338191

Other Identifiers

ISSN

0007-1250

E-ISSN

1472-1465

DOI

10.1192/bjp.bp.111.105833

How to access this item